CSI Market
Sign In | Register

Nektar Therapeutics (NKTR) Annual Balance Sheets

Annual · GAAP · USD millions
Access NKTR quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Nektar Therapeutics adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent15.12
Available-for-sale Securities, Debt Securities, Current MA230.64
Cash & Short-term Investments245.00
Accounts receivable0.00
Inventories0.00
Other Current Assets20.51
Total Current Assets266.27
Equipment/Property/Plant Net2.06
Goodwill net0.00
Long-term investments3.49
Other Assets, Noncurrent12.08
Operating Lease Right Of Use Asset2.94
Total Assets280.41
Liabilities
Accounts Payable, Current AC10.77
Accrued Liabilities, Current AC22.27
Other Liabilities, Current20.50
Total Current Liabilities53.54
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent137.04
Accrued Clinical Trial Expenses Current-
Operating Lease Liability Current20.50
Operating Lease Liability Noncurrent65.26
Total Liabilities190.57
Stockholders' Equity
Common Stock Value0.00
Treasury Stock Value0.00
Additional Paid In Capital Common Stock3,850.10
Retained Earnings / Accumulated Deficit-3,760.29
Other Equity0.02
Common Stockholder's Equity89.83
Total Stockholder's Equity89.83
Liabilities & Stockholder's Equity280.41
4 historic quarters locked

Sign in to unlock the full Nektar Therapeutics balance sheet history.

Sign In Create Free Account

About Nektar Therapeutics Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-104547

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License